GlassScriptPhysician profile
Randy W Hawkins
NPI 1760580971
$11,617.66
in general payments reported to CMS, 2019-2025
48 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,634 · 2020: $523 · 2021: $659 · 2022: $1,639 · 2023: $1,607 · 2024: $2,020 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,962 · Education: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,962.03 |
| Education | $202.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,401.96 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,242.37 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,137.87 | 2019-2025 | Ofev, Jascayd, Jardiance |
| Genzyme Corporation | $1,040.79 | 2021-2025 | |
| Gilead Sciences, INC. | $833.32 | 2020-2025 | Veklury |
| Viiv Healthcare Company | $557.37 | 2019-2025 | Apretude, Dovato |
| Novo Nordisk INC | $487.97 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $366.53 | 2019-2025 | |
| Amarin Pharma, INC. | $333.60 | 2019 | |
| Abbvie INC. | $322.64 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $321.62 | 2019-2024 | |
| Genentech USA, INC. | $255.37 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $247.23 | 2019-2024 | |
| Alkermes, INC. | $246.29 | 2025 | Aristada, Lybalvi, Aristada Initio |
| Lexicon Pharmaceuticals, INC. | $245.32 | 2024 | Inpefa |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Hawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.